View in EDS PDF Full Text

E2F4 is required for cardiomyocyte proliferation.

Saved in:
Bibliographic Details
Title: E2F4 is required for cardiomyocyte proliferation.
Authors: van Amerongen MJ; Department of Cardiac Development and Remodelling, Excellence Cluster Cardio-Pulmonary System, Max-Planck-Institute for Heart and Lung Research, Parkstrasse 1, Bad Nauheim 61231, Germany., Diehl F, Novoyatleva T, Patra C, Engel FB
Source: Cardiovascular research [Cardiovasc Res] 2010 Apr 01; Vol. 86 (1), pp. 92-102. Date of Electronic Publication: 2009 Dec 02.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-3245 (Electronic) Linking ISSN: 00086363 NLM ISO Abbreviation: Cardiovasc Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 19955219
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: E2F4 is required for cardiomyocyte proliferation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22van+Amerongen+MJ%22">van Amerongen MJ</searchLink>; Department of Cardiac Development and Remodelling, Excellence Cluster Cardio-Pulmonary System, Max-Planck-Institute for Heart and Lung Research, Parkstrasse 1, Bad Nauheim 61231, Germany.<br /><searchLink fieldCode="AU" term="%22Diehl+F%22">Diehl F</searchLink><br /><searchLink fieldCode="AU" term="%22Novoyatleva+T%22">Novoyatleva T</searchLink><br /><searchLink fieldCode="AU" term="%22Patra+C%22">Patra C</searchLink><br /><searchLink fieldCode="AU" term="%22Engel+FB%22">Engel FB</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220077427%22">Cardiovascular research</searchLink> [Cardiovasc Res] 2010 Apr 01; Vol. 86 (1), pp. 92-102. <i>Date of Electronic Publication: </i>2009 Dec 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+Journals%22">Oxford Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0077427 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1755-3245 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200086363%22">00086363 </searchLink><i>NLM ISO Abbreviation: </i>Cardiovasc Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=19955219
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cvr/cvp383
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 92
    Titles:
      – TitleFull: E2F4 is required for cardiomyocyte proliferation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: van Amerongen MJ
      – PersonEntity:
          Name:
            NameFull: Diehl F
      – PersonEntity:
          Name:
            NameFull: Novoyatleva T
      – PersonEntity:
          Name:
            NameFull: Patra C
      – PersonEntity:
          Name:
            NameFull: Engel FB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2010 Apr 01
              Type: published
              Y: 2010
          Identifiers:
            – Type: issn-electronic
              Value: 1755-3245
          Numbering:
            – Type: volume
              Value: 86
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cardiovascular research
              Type: main
ResultId 1